XML 65 R55.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segment Information - Results and Reconciliation of Operating Loss to Adjusted EBITDA (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Oct. 01, 2021
Sep. 30, 2022
Oct. 01, 2021
Net sales $ 383,814 $ 359,923 $ 1,154,388 $ 1,027,130
Adjusted EBITDA (non-GAAP) 57,209 56,472 161,126 144,371
Operating loss (GAAP) (17,919) (16,107) (42,993) (44,589)
Restructuring and other related charges 2,989 2,230 8,497 5,193
MDR and other costs 3,600 1,902 10,648 5,574
Strategic transaction costs 8,146 11,362 32,549 15,780
Stock-based compensation 7,205 6,253 21,734 19,000
Depreciation and other amortization 18,159 18,397 56,109 51,639
Amortization of acquired intangibles 31,993 31,025 94,603 88,067
Insurance settlement (gain) loss 975 0 (32,059) 0
Inventory step-up 2,061 1,410 12,038 3,707
Cost of Sales        
Restructuring and other related charges     800  
Prevention and Recovery        
Net sales 256,502 256,229 765,121 757,822
Adjusted EBITDA (non-GAAP) 39,532 40,432 101,050 94,982
Reconstructive Segment        
Net sales 127,312 103,694 389,267 269,308
Adjusted EBITDA (non-GAAP) $ 17,677 $ 16,040 $ 60,076 $ 49,389